CAS 640-79-9|Glycochenodeoxycholic acid

Introduction:Basic information about CAS 640-79-9|Glycochenodeoxycholic acid, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameGlycochenodeoxycholic acid
CAS Number640-79-9Molecular Weight449.62300
Density/Boiling Point/
Molecular FormulaC26H43NO5Melting Point/
MSDS/Flash Point/

Names

Nameglycochenodeoxycholic acid
SynonymMore Synonyms

Glycochenodeoxycholic acid BiologicalActivity

DescriptionGlycochenodeoxycholic acid is a bile salt formed in the liver from chenodeoxycholate and glycine; used to induce hepatocyte apoptosis in research.
Related CatalogSignaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>CancerNatural Products >>Steroids
Target

Human Endogenous Metabolite

In VitroChenodeoxycholate is toxic to hepatocytes, and accumulation of chenodeoxycholate in the liver during cholestasis may potentiate hepatocellular injury. At a concentration of 250μM, glycochenodeoxycholate is more toxic than either chenodeoxycholate or taurochenodeoxycholate. Glycochenodeoxycholate cytotoxicity may result from ATP depletion followed by a subsequent rise in Ca2+. The rise in Ca2+ leads to an increase in calcium-dependent degradative proteolysis and, ultimately, cell death[1]. 4 h exposure of 50 μM GCDC induces apoptosis in 42% of hepatocytes. Intracellular PKC activity decreased to 44% of controls 2 h after exposure of hepatocytes to GCDC. GCDC-induced apoptosis is associated with decreases in total cellular PKC activity, which appear to be dependent on intracellular calpain-like protease activity[2].
In VivoGCDCA induces ER-related calcium release within about ten seconds. Significant increases in activities of calpain and caspase-12 are observed after 15 h of GCDCA treatment. Bip and Chop mRNA expressions are increased with the treated GCDCA dose and incubation time. Cytochrome c release from mitochondria peaks in about 2 h of incubation[3].
Animal AdminRats: The freshly isolated hepatocytes are preincubated for 2 h at a density of 1× 106 cells/mL in a mixture of William’s E medium supplement with 10% FBS. Isolated rat hepatocytes are incubated in William’s E medium with or without (used as a control) GCDCA (50, 100 and 300 μM), or TG (1, 2 and 5 μM) for 1-24 h[3].
References

[1]. Spivey JR, et al. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest. 1993 Jul;92(1):17-24.

[2]. Gonzalez B, et al. Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular PKC activity. Mol Cell Biochem. 2000 Apr;207(1-2):19-27.

[3]. Tsuchiya S, et al. Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rathepatocytes. Toxicol Lett. 2006 Oct 10;166(2):140-9.

Chemical & Physical Properties

Molecular FormulaC26H43NO5
Molecular Weight449.62300
Exact Mass449.31400
PSA110.35000
LogP4.43440
InChIKeyGHCZAUBVMUEKKP-GYPHWSFCSA-N
SMILESCC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C
Storage condition-20°C

Synonyms

Chenodeoxycholylglycine
[3H]-Glycylchenodeoxycholic acid
[14C]-Glycylchenodeoxycholic acid
2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
Glycine chenodeoxycholate
Chenodeoxyglycocholic acid
Chenodeoxycholic acid glycine conjugate
Glycochenodeoxycholate
Chenodeoxyglycocholate
CAS 5259-87-0|N-(Phenylacetyl)glycine methyl ester
CAS 172669-64-6|Glycyl-L-glutamine Monohydrate
Recommended......
TOP